| Literature DB >> 32582396 |
Yong-Jin Park1, Mu Heon Shin1, Seung Hwan Moon1.
Abstract
Radiogenomics or imaging genomics is a novel omics strategy of associating imaging data with genetic information, which has the potential to advance personalized medicine. Imaging features extracted from PET or PET/CT enable assessment of in vivo functional and physiological activity and provide comprehensive tumor information non-invasively. However, PET features are considered secondary to features on conventional imaging, and there has not yet been a review of the radiogenomic approach using PET features. This review article summarizes the current state of PET-based radiogenomic research for cancer, which discusses some of its limitations and directions for future study. © Korean Society of Nuclear Medicine 2020.Entities:
Keywords: Oncology; Positron emission tomography (PET); Radiogenomics
Year: 2020 PMID: 32582396 PMCID: PMC7295928 DOI: 10.1007/s13139-020-00642-x
Source DB: PubMed Journal: Nucl Med Mol Imaging ISSN: 1869-3474